Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model

被引:44
|
作者
Alici, Evren [1 ]
Konstantinidis, Kyriakos V. [1 ]
Sutlu, Tolga [1 ]
Aints, Alar [1 ]
Gahrton, Gosta [1 ]
Ljunggren, Hans-Gustaf [1 ]
Dilber, M. Sirac [1 ]
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden
关键词
D O I
10.1016/j.exphem.2007.08.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Despite advances in autologous stem cell transplantation and chemotherapy, multiple myeloma (MM) remains an incurable disease. Due to the role of natural killer (NK) cells in host resistance against several tumors, it is of interest to explore the anti-MM activity of NK cells. For this reason, we aimed to determine if NK cells provide anti-MM activity following interleukin-2 (IL-2) administration, and if ex vivo activated and intravenously administered NK cells prolong survival in MM-bearing C57BL/KaLwRij mice. Methods. The anti-MM effect of IL-2 was tested by intraperitoneal injection into the 5T33MM-inoculated mice. Subsequently, in vivo effector cell depletions were performed by administration of anti-NK1.1 or anti-CD8 monoclonal antibodies. Finally, magnetically separated and activated NK cells from splenocytes of C57BL/KaLwRij mice were adoptively transferred to tumor-bearing mice in conjunction with IL-2 treatment. Results. IL-2 administration into MM-bearing mice significantly prolonged their survival. This effect was diminished by in vivo depletion of NK cells. Adoptive transfer of activated NK cells showed a significant in vivo anti-MM effect that was dependent on cell dose. Biodistribution of the marked adoptively transferred NK cells correlated with MM cells' homing sites. Conclusion. These data suggest that activated NK cells have a promising potential in adoptive immunotherapy for MM. (C) 2007 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.
引用
收藏
页码:1839 / 1846
页数:8
相关论文
共 50 条
  • [1] Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
    Bonanni, Valentina
    Antonangeli, Fabrizio
    Santoni, Angela
    Bernardini, Giovanni
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [2] Anti-myeloma activity of natural killer lymphocytes
    Frohn, C
    Höppner, M
    Schlenke, P
    Kirchner, H
    Koritke, P
    Luhm, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 660 - 664
  • [3] Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
    Leivas, Alejandra
    Perez-Martinez, Antonio
    Jesus Blanchard, Maria
    Martin-Clavero, Estela
    Fernandez, Lucia
    Jose Lahuerta, Juan
    Martinez-Lopez, Joaquin
    ONCOIMMUNOLOGY, 2016, 5 (12):
  • [4] Translating the anti-myeloma activity of Natural Killer cells into clinical application
    Fionda, Cinzia
    Stabile, Helena
    Molfetta, Rosa
    Soriani, Alessandra
    Bernardini, Giovanni
    Zingoni, Alessandra
    Gismondi, Angela
    Paolini, Rossella
    Cippitelli, Marco
    Santoni, Angela
    CANCER TREATMENT REVIEWS, 2018, 70 : 255 - 264
  • [5] Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo
    Garg, Tarun K.
    Szmania, Susann
    Malbrough, Paul
    Ekworomadu, Charles
    Stone, Katie
    Moreno-Bost, Amberly
    Woods, Emily
    Shi, Jumei
    Yaccoby, Shmuel
    Shaughnessy, John D., Jr.
    Barlogie, Bart
    Campana, Dario
    van Rhee, Frits
    BLOOD, 2009, 114 (22) : 393 - 394
  • [6] Anti-myeloma activity and molecular logic operation by Natural Killer cells in microfluidic droplets
    Sarkar, Saheli
    McKenney, Seamus
    Sabhachandani, Pooja
    Adler, James
    Hu, Xiaozhe
    Stroopinksy, Dina
    Rosenblatt, Jacalyn
    Avigan, David
    Konry, Tania
    SENSORS AND ACTUATORS B-CHEMICAL, 2019, 282 : 580 - 589
  • [7] Anti-myeloma Effect of Xanthohumol on Multiple Myeloma Cells
    Tucker, Michael
    Rayalam, Srujana
    Wang, Xinyu
    FASEB JOURNAL, 2020, 34
  • [8] NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
    Petillo, Sara
    Sproviero, Elena
    Loconte, Luisa
    Cuollo, Lorenzo
    Zingoni, Alessandra
    Molfetta, Rosa
    Fionda, Cinzia
    Soriani, Alessandra
    Cerboni, Cristina
    Petrucci, Maria Teresa
    Fazio, Francesca
    Paolini, Rossella
    Santoni, Angela
    Cippitelli, Marco
    CELL DEATH & DISEASE, 2023, 14 (07)
  • [9] NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells
    Sara Petillo
    Elena Sproviero
    Luisa Loconte
    Lorenzo Cuollo
    Alessandra Zingoni
    Rosa Molfetta
    Cinzia Fionda
    Alessandra Soriani
    Cristina Cerboni
    Maria Teresa Petrucci
    Francesca Fazio
    Rossella Paolini
    Angela Santoni
    Marco Cippitelli
    Cell Death & Disease, 14
  • [10] Synergistic anti-myeloma activity by combination of dendritic cells, pomalidomide and dexamethasone in a murine myeloma model
    Vo, M. C.
    Yang, S.
    Chu, T. H.
    Jung, S. H.
    Lee, H. J.
    Lakshmi, T. J.
    Park, H. S.
    Kim, H. J.
    Rhee, J. H.
    Lee, J. J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 92 - 93